| Mrs Gina Kay Johnson, LPN | |
|
4200 E 61st St, Kansas City, MO 64130-4621 | |
| (816) 309-9733 | |
| Not Available |
| Full Name | Mrs Gina Kay Johnson |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 4200 E 61st St, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437432697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 2007028790 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Gina Kay Johnson, LPN 4200 E 61st St, Kansas City, MO 64130-4621 Ph: (816) 822-2383 | Mrs Gina Kay Johnson, LPN 4200 E 61st St, Kansas City, MO 64130-4621 Ph: (816) 309-9733 |
News Archive
"Most people think malnutrition is all about not having enough food or enough of the right kind of food to eat," but while "this is a big part of the story ... there are many other links in the chain," Lawrence Haddad, director of the Institute of Development Studies, writes in a BBC Magazine opinion piece.
In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.
The company is pleased to announce that after receiving Ethical Committee (EC) and Ministry of Health (MOH) approval, for the first human use of the company's FastSeal Bioabsorbable Vascular Access Closure System, Phase I of the First in Human (FIH) clinical testing has been completed, with 100% successful results, and no adverse effects, including post procedural discomfort.
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that it has been informed that percutaneous tibial nerve stimulation (PTNS), the procedure performed using the Uroplasty Urgent PC Neuromodulation System, will receive a category 1 CPT reimbursement code. This is expected to occur when those codes are published by the Centers for Medicare and Medicaid Services, which is expected in October 2010.
› Verified 2 days ago
Catherine Marinan, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4801 E Linwood Blvd, Kansas City, MO 64128 Phone: 816-861-4700 | |
Mrs. Amanda Lee Hevalow, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 723 E 18th St, Kansas City, MO 64108 Phone: 816-283-3877 Fax: 816-283-3310 | |
Ryan Goss, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4801 E Linwood Blvd, Kansas City, MO 64128 Phone: 816-861-4700 | |
Tiffany M Mitchell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 E 24th St, Kansas City, MO 64108 Phone: 440-339-4714 | |
Julie Mcneill, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8333 E Blue Pkwy, Kansas City, MO 64133 Phone: 816-474-7677 Fax: 816-767-7671 | |
Ecclesietta Ophelia Boyd, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11021 Greenwood Rd, Kansas City, MO 64134 Phone: 913-749-6419 | |
Mrs. Gaela Anne Fisher, LPN/ Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 13201 E. 53rd Street, Kansas City, MO 64133 Phone: 816-786-9532 |